Skip to main content
SpringerLink
Log in

Quality of Life with CNS Metastasis

  • Chapter
  • First Online:
Central Nervous System Metastasis, the Biological Basis and Clinical Considerations

Part of the book series: Cancer Metastasis - Biology and Treatment ((CMBT,volume 18))

  • 859 Accesses

Abstract

Quality of life (QOL) is a concept that involves an individual’s general sense of well-being and satisfaction, and may include concerns regarding physical ability and comfort, mental health and sense of autonomy, and social situation (including relationship and economic factors). Given the generally poor prognosis and survival for persons with central nervous system (CNS) metastases, addressing concerns about and enhancing QOL for patients is vital, particularly as many patients report poor quality of life prior to engaging in treatment for the metastases. This chapter addresses important topics related to QOL for such patients, including common difficulties encountered in assessment of QOL, instruments used to ­evaluate QOL, predictors of better perceived quality of life (e.g., disease ­parameters, treatment, and psychological factors), and interventions to support QOL in ­individuals with CNS metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ochs J, Mulhern R, Kun L (1988) Quality-of-life assessment in cancer patients. Am J Clin Oncol 11:413–421

    Article  Google Scholar 

  2. Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York

    Google Scholar 

  3. Schag CC, Heinrich RL, Ganz PA (1984) Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 2:187–193

    PubMed  CAS  Google Scholar 

  4. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655

    Article  PubMed  CAS  Google Scholar 

  5. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:914–919

    Article  PubMed  CAS  Google Scholar 

  6. Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Md State Med J 14:61–65

    PubMed  CAS  Google Scholar 

  7. Heinemann AW, Linacre JW, Wright BD, Hamilton BB, Granger C (1994) Measurement ­characteristics of the Functional Independence Measure. Top Stroke Rehabil 1:1–15

    Google Scholar 

  8. Gasper L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751

    Article  Google Scholar 

  9. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR (1981) Measuring the quality of life of cancer patients: a concise QL-index for use by ­physicians. J Chronic Dis 34:585–597

    Article  PubMed  CAS  Google Scholar 

  10. Scott C, Suh J, Stea B, Nabid A, Hackman J (2007) Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases. Am J Clin Oncol 30:580–587

    Article  PubMed  CAS  Google Scholar 

  11. Chang VT, Hwang SS, Feuerman M (2000) Validation of the Edmonton symptom assessment scale. Cancer 88:2164–2171

    Article  PubMed  CAS  Google Scholar 

  12. Weitzner MA, Meyers CA, Gelke CJ, Byrne KS, Cella DF, Levin VA (1995) The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and ­revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75:1151–1161

    Article  PubMed  CAS  Google Scholar 

  13. Osoba D, Aaronson NK, Muller M et al (1996) The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general ­cancer-specific questionnaires. Qual Life Res 5:139–150

    Article  PubMed  CAS  Google Scholar 

  14. Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD (2005) Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients’ perspective regarding complications. Am J Clin Oncol 28:173–179

    Article  PubMed  Google Scholar 

  15. Rogers MP, Orav J, Black PM (2001) The use of a simple Likert scale to measure quality of life in brain tumor patients. J Neurooncol 55:121–131

    Article  PubMed  CAS  Google Scholar 

  16. Sehlen S, Lenk M, Hollenhorst H et al (2003) Quality of life (QOL) as predictive mediator variable for survival in patients with intracerebral neoplasma during radiotherapy. Onkologie 26:38–43

    Article  PubMed  CAS  Google Scholar 

  17. Wong J, Hird A, Kirou-Mauro A, Napolskikh J, Chow E (2008) Quality of life in brain metastases radiation trials: a literature review. Curr Oncol 15:25–45

    Article  PubMed  CAS  Google Scholar 

  18. Armstrong TS, Gning I, Mendoza TR, Weinberg JS, Gilbert MR, Tortorice ML, Cleeland CS (2009) Clinical utility of the MDASI-BT in patients with brain metastases. J Pain Symptom Manage 27:331–340

    Article  Google Scholar 

  19. Bordeleau L, Szalai JP, Ennis M et al (2003) Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data. J Clin Oncol 21:1944–1951

    Article  PubMed  Google Scholar 

  20. Doyle M, Bradley NM, Li K et al (2007) Quality of life in patients with brain metastases treated with palliative course of whole-brain radiotherapy. J Pallit Med 10:367–374

    Article  Google Scholar 

  21. Gerrard GE, Prestwich RJ, Edwards A, Russon LJ, Richards F, Johnston CF, Kwok-Williams MC (2003) Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features. Clin Oncol 15:422–428

    Article  CAS  Google Scholar 

  22. Roos DE, Wirth A, Burmeister BH et al (2006) Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05). Radiother Oncol 80:318–322

    Article  PubMed  Google Scholar 

  23. Sneeuw KC, Aaronson NK, Osoba D et al (1997) The use of significant others as proxy raters of the quality of life in patients with brain cancer. Med Care 35:490–506

    Article  PubMed  CAS  Google Scholar 

  24. Gil Z, Abergel A, Spektor S, Khafif A, Fliss DM (2004) Patient, caregiver, and surgeon perceptions of quality of life following anterior skull base surgery. Arch Otolaryngol Head Neck Surg 130:1276–1281

    Article  PubMed  Google Scholar 

  25. Cella DF (1996) Quality of life outcomes: measurements and validation. Oncology 10:233–244

    PubMed  CAS  Google Scholar 

  26. Miao Y, Lu X, Qui Y, Jiang J, Lin Y (2010) A multivariate analysis of prognostic factors for health-related quality of life in patients with surgically managed meningioma. J Clin Neurosci 17:446–449

    Article  PubMed  Google Scholar 

  27. Osoba D, Brada M, YungWK PM (2000) Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. J Clin Oncol 18:1481–1491

    PubMed  CAS  Google Scholar 

  28. Taphoorn MJ, Stupp R, Coens C et al (2005) Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 6:937–944

    Article  PubMed  Google Scholar 

  29. Taphoorn MJ, van den Bent MJ, Mauer ME et al (2007) Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organization for Research and Treatment of Cancer randomized clinical trial. J Clin Oncol 25:5723–5730

    Article  PubMed  Google Scholar 

  30. Giovagnoli AR, Silvani A, Colombo E, Boiardi A (2005) Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 76:562–568

    Article  PubMed  CAS  Google Scholar 

  31. Taphoorn MJ, Sizoo EM, Bottomley A (2010) Review on quality of life issues in patients with primary brain tumors. Oncologist 15:618–626

    Article  PubMed  Google Scholar 

  32. Janda M, Steginga S, Langbecker D, Dunn J, Walker D, Eakin E (2007) Quality of life among patients with a brain tumor and their carers. J Psychosom Res 63:617–623

    Article  PubMed  Google Scholar 

  33. Osoba D, Brada M, Prados MD, Yung WK (2000) Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro Oncol 2:221–228

    PubMed  CAS  Google Scholar 

  34. Brown PD, Maurer MJ, Rummans TA et al (2005) A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on ­quality of life and survival. Neurosurgery 57:495–504

    Article  PubMed  Google Scholar 

  35. Wong J, Hird A, Zhang L, Tsao M, Sinclair E, Barnes E, Danjoux C, Chow E (2009) Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy. Int J Radiat Oncol Biol Phys 75:1125–1131

    Article  PubMed  Google Scholar 

  36. Addeo R, Caraglia M, Faiola V et al (2007) Concomitant treatment of brain metastasis with whole brain radiotherapy (WBRT) and temozolomide (TMZ) is active and improves quality of life. BMC Cancer 7:18

    Article  PubMed  CAS  Google Scholar 

  37. Yaneva MP, Semerdjieva MA (2006) Assessment of the effect of palliative radiotherapy for cancer patients with intracranial metastases using EORTC-QOL-C30 questionnaire. Folia Med 48:23–29

    Google Scholar 

  38. Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P (2006) Gender difference in relation to depression and quality of life among patients with primary brain tumor. Eur Psychiatry 21:194–199

    Article  PubMed  Google Scholar 

  39. Weitzner MA, Meyers CA (1996) Quality of life and neurobehavioral functioning in patients with malignant gliomas. In: Yung W (ed) Baillière’s clinical neurology: cerebral gliomas, vol 5. Baillière Tindall, London, pp 425–439

    Google Scholar 

  40. Wadhwa D, Burman D, Swami N, Rodin G, Lo C, Zimmerman C (2011) Quality of life and mental health in caregivers of outpatients with advanced cancer. Psychooncology. doi:10.1002/pon.2104

  41. DiBiase SJ, Chin LS, Ma L (2002) Influence of gamma knife radiosurgery on the quality of life in patients with brain metastases. Am J Clin Oncol 25:131–134

    Article  PubMed  Google Scholar 

  42. Mehta MP, Dhapiro WR, Glantz MJ et al (2002) Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic endpoints. J Clin Oncol 20:3445–3453

    Article  PubMed  CAS  Google Scholar 

  43. Platta CS, Khuntia D, Mehta MP, Suh JH (2010) Current treatment strategies for brain metastasis and complications from therapeutic techniques: a review of current literature. Am J Clin Oncol 33:398–407

    Article  PubMed  Google Scholar 

  44. Ferguson RJ, Ahles TA (2003) Low neuropsychologic performance among adult cancer survivors treated with chemotherapy. Curr Neurol Neurosci Rep 3:215–222

    Article  PubMed  Google Scholar 

  45. Inagaki M, Yoshikawa E, Matsuoka Y, Sugawara Y, Nakano T, Akechi T, Wada N, Imoto S, Murakami K, Uchitomi Y (2007) Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 109:146–156

    Article  PubMed  Google Scholar 

  46. Kayl AE, Wefel JS, Meyers CA (2006) Chemotherapy and cognition: effects, potential ­mechanisms, and management. Am J Ther 13:362–369

    Article  PubMed  Google Scholar 

  47. Li J, Bentzen SM, Renschler M, Mehta MP (2007) Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 25:1260–1266

    Article  PubMed  Google Scholar 

  48. Chang EL, Wefel JS, Maor MH, Hassenbusch SJ 3rd, Mahajan A, Lang FF, Woo SY, Matthews LA, Allen PK, Shiu AS, Meyers CA (2007) A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 60:277–283

    PubMed  Google Scholar 

  49. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole brain irradiation: a randomized controlled trial. Lancet Oncol 10:1037–1044

    Article  PubMed  Google Scholar 

  50. Sneed PK, Lamborn KR, Forstner JM, McDermott MW, Chang S, Park E, Gutin PH, Phillips TL, Wara WM, Larson DA (1999) Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43:549–558

    Article  PubMed  CAS  Google Scholar 

  51. Meyers CA, Smith JA, Bezjak A, Mehta MP et al (2004) Neurocognitive function and ­progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22:157–165

    Article  PubMed  CAS  Google Scholar 

  52. Wan GJ, Counte MA, Cella DF (1997) The influence of personal expectations on cancer patients’ reports of health-related quality of life. Psychooncology 6:1–11

    Article  PubMed  CAS  Google Scholar 

  53. Greer S, Morris T, Pettingale KW (1979) Psychological response to breast cancer: effect on outcome. Lancet 2:785–787

    Article  PubMed  CAS  Google Scholar 

  54. Petticrew M, Bell R, Hunter D (2002) Influence of psychological coping on survival and ­recurrence in people with cancer: systemic review. BMJ 325:1066–1069

    Article  PubMed  Google Scholar 

  55. Fawzy FI, Fawzy NW, Hyun CS, Elashoff R, Guthrie D, Fahey JL et al (1993) Malignant ­melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 50:681–689

    Article  PubMed  CAS  Google Scholar 

  56. Spiegel D, Bloom JR, Kraemer HC, Gottheil E (1989) Effect of psychosocial treatment on survival of patients with metastatic cancer. Lancet 2:888–891

    Article  PubMed  CAS  Google Scholar 

  57. Coyne JC, Stephanek M, Palmer SC (2007) Psychotherapy and survival in cancer: the conflict between hope and evidence. Psychol Bull 133:367–394

    Article  PubMed  Google Scholar 

  58. Paton C, Perez D (2006) Psychosocial variables as prognostic factors in metastatic cancer: a brief review. N Z Med J 119(1237):U2054

    PubMed  Google Scholar 

  59. Cassileth BR, Lusk EJ, Strouse TB, Miller DS, Brown LL, Cross PA, Tenaglia AN (1984) Psychosocial status in chronic illness: a comparative analysis of six diagnostic groups. N Engl J Med 311:506–511

    Article  PubMed  CAS  Google Scholar 

  60. Clarke DM, McLeod JE, Smith GC, Trauer T, Kissane DW (2005) A comparison of psychosocial and physical functioning in patients with motor neurone disease and metastatic cancer. J Palliat Care 21:173–179

    PubMed  Google Scholar 

  61. Andrykowski MA, Lykins E, Floyd A (2008) Psychological health in cancer survivors. Semin Oncol Nurs 24:193–201

    Article  PubMed  Google Scholar 

  62. Hyphantis T, Paika V, Almyroudi A, Kampletsas EO, Pavlidis N (2011) Personality variables as predictors of early non-metastatic colorectal cancer patents’ psychological distress and health-related quality of life: a one-year prospective study. J Psychosom Res 70:411–421

    Article  PubMed  Google Scholar 

  63. Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P (2005) Depression and functional outcome in patients with brain tumors: a population-based 1-year follow-up study. J Neurosurg 103:841–847

    Article  PubMed  Google Scholar 

  64. Mainio A, Hakko H, Timonen M, Niemela A, Koivukangas J, Rasanen P (2005) Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery 56:1234–1241

    Article  PubMed  Google Scholar 

  65. Paika V, Aimyroudi A, Tomenson B, Creed F, Kampletsas EO, Siafaka V, Gkika S, Mavreas V, Pavlidis N, Hyphantis T (2010) Personality variables are associated with colorectal cancer patients’ quality of life independent of psychological distress and disease severity. Psychooncology 19:273–282

    Article  PubMed  Google Scholar 

  66. Valente SM, Saunders JM, Cohen MZ (1994) Evaluating depression among patients with cancer. Cancer Pract 2:65–71

    PubMed  CAS  Google Scholar 

  67. Fulton CL (1997) The physical and psychological symptoms experienced by patients with metastatic breast cancer before death. Eur J Cancer Care 6:262–266

    Article  CAS  Google Scholar 

  68. Beck AT, Rush AJ, Shaw BF, Emery G (1979) Cognitive therapy of depression. The Guilford Press, New York

    Google Scholar 

  69. Antoni MH, Lehman JM, Klibourn KM, Boyers AE, Culver JL, Alferi SM, Yount SE, McGregor BA, Arena PL, Harris SD, Price AA, Carver CS (2001) Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol 20:20–32

    Article  PubMed  CAS  Google Scholar 

  70. Edelman S, Lemon J, Bell DR, Kidman AD (1999) Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology 8:474–481

    Article  PubMed  CAS  Google Scholar 

  71. Lévesque M, Savard J, Simard S, Gauthier JG, Ivers H (2004) Efficacy of cognitive therapy for depression among women with metastatic cancer: a single-case experimental study. J Behav Ther Exp Psychiatry 35:287–305

    Article  PubMed  Google Scholar 

  72. Meyers CA, Weitzner MA, Valentine AD et al (1998) Methylphenidate improves cognition, mood, and function of brain tumor patients. J Clin Oncol 16:2522–2527

    PubMed  CAS  Google Scholar 

  73. Gustafsson M, Edvardsson T, Ahlstrom G (2006) The relationship between function, quality of life, and coping in patients with low-grade gliomas. Support Care Cancer 14:1205–1212

    Article  PubMed  Google Scholar 

  74. Liu R, Page M, Solheim K, Fox S, Chang SM (2010) Quality of life in adults with brain tumors: current knowledge and future directions. Neuro Oncol 11:330–339

    Article  Google Scholar 

  75. Brown PD, Ballman KV, Rummans TA et al (2006) Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol 76:283–291

    Article  PubMed  Google Scholar 

  76. Salo J, Niemela A, Joukamaa M, Kolvukangas J (2002) Effect of brain tumour laterality on patents’ perceived quality of life. J Neurol Neurosurg Psychiatry 72:373–377

    Article  PubMed  CAS  Google Scholar 

  77. Chow E, Davis L, Holden L, Tsao M, Danjoux C (2005) Prospective assessment of ­patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage 30:18–23

    Article  PubMed  Google Scholar 

  78. Lohr F, Pirzkall A, Hof H, Fleckenstein K, Debus J (2001) Adjuvant treatment of brain ­metastases. Semin Surg Oncol 20:50–56

    Article  PubMed  CAS  Google Scholar 

  79. Headley J, Ownby K, John L (2004) The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer. Oncol Nurs Forum 31:977–983

    Article  PubMed  Google Scholar 

  80. Crevenna R, Fialka-Moser V, Keilani M, Schmidinger M, Marosi C, Quittan M (2002) Aerobic physical training in a breast cancer patient with inflammatory recurrence. Wien Med Wochenschr 152:581–584

    Article  PubMed  CAS  Google Scholar 

  81. Crevenna R, Schmidinger M, Keilani M, Nuhr M, Fialka-Moser V, Zettinig G, Quittan M (2003) Aerobic exercise for a patient suffering from metastatic bone disease. Support Care Cancer 11:120–122

    PubMed  CAS  Google Scholar 

  82. Oldervoll LM, Loge JH, Paltiel H, Asp MB, Vidvei U, Wiken AN, Hjermstad MJ, Kaasa S (2006) The effect of a physical exercise program on palliative care: a phase II study. J Pain Symptom Manage 31:421–430

    Article  PubMed  Google Scholar 

  83. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR (2005) Randomized ­controlled trial of exercise and blood immune function in post-menopausal breast cancer ­survivors. J Appl Physiol 98:1534–1540

    Article  PubMed  Google Scholar 

  84. Tang V, Rathbone M, Dorsay JP, Jiang S, Harvey D (2008) Rehabilitation in primary and ­metastatic brain tumors: impact of functional outcomes on survival. J Neurol 255:820–827

    Article  PubMed  CAS  Google Scholar 

  85. Marciniak CM, Sliwa JA, Heinemann AW, Semik PE (2001) Functional outcomes of persons with brain tumors after inpatient rehabilitation. Arch Phys Med Rehabil 82:457–463

    Article  PubMed  CAS  Google Scholar 

  86. O’Dell MW, Barr K, Spanier D, Warnick RE (1998) Functional outcome of inpatient rehabilitation in persons with brain tumors. Arch Phys Med Rehabil 79:1530–1534

    Article  PubMed  Google Scholar 

  87. Greenberg E, Treger I, Ring H (2006) Rehabilitation outcomes in patients with brain tumors and acute stroke: comparative study of inpatient rehabilitation. Am J Phys Med Rehabil 85:568–573

    Article  PubMed  Google Scholar 

  88. Huang ME, Cifu DX, Keyser-Marcus L (1998) Functional outcome after brain tumor and acute stroke: a comparative analysis. Arch Phys Med Rehabil 79:1386–1390

    Article  PubMed  CAS  Google Scholar 

  89. Huang ME, Cifu DX, Keyser-Marcus L (2000) Functional outcomes in patients with brain tumor after inpatient rehabilitation: comparison with traumatic brain injury. Am J Phys Med Rehabil 79:327–335

    Article  PubMed  CAS  Google Scholar 

  90. Stephenson NL, Swanson M, Dalton J, Keefe FJ, Engelke M (2007) Partner-delivered reflexology: effects on cancer pain and anxiety. Oncol Nurs Forum 34:127–132

    Article  PubMed  Google Scholar 

  91. Classen C, Butler LD, Koopman C et al (2001) Supportive-expressive group therapy and ­distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry 58:494–501

    Article  PubMed  CAS  Google Scholar 

  92. Edelman S, Bell DR, Kidman AD (1999) A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psychooncology 8:295–305

    Article  PubMed  CAS  Google Scholar 

  93. Goodwin PJ, Leszcz M, Ennis M et al (2001) The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 345:1719–1726

    Article  PubMed  CAS  Google Scholar 

  94. Kissane DW, Grabsch B, Clarke DM, Smith GC, Love AW, Bloch S, Snyder RD, Yuelin L (2007) Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology 16:277–286

    Article  PubMed  Google Scholar 

  95. Spiegel D, Bloom JR, Yalom I (1981) Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiatry 38:527–533

    Article  PubMed  CAS  Google Scholar 

  96. Edmonds CV, Lockwood GA, Cunningham AJ (1999) Psychological response to long-term group therapy: a randomized trial with metastatic breast cancer patients. Psychooncology 8:74–91

    Article  PubMed  CAS  Google Scholar 

  97. Dorman S, Hayes J, Pease N (2009) What do patients with brain metastases from non-small cell lung cancer want from their treatment? Palliat Med 23:594–600

    Article  PubMed  CAS  Google Scholar 

  98. Mangan PA, Taylor KL, Yabroff KR, Fleming DA, Ingham JM (2003) Caregiving near the end of life: unmet needs and potential solutions. Palliat Support Care 1:247–259

    Article  PubMed  Google Scholar 

  99. Yates JW, Chalmer B, Mckegney P (1980) Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45:2220–2224

    Article  PubMed  CAS  Google Scholar 

  100. Forster LE, Lynn J (1988) Predicting life span for applicants to inpatient hospice. Arch Intern Med 148:2540–2543

    Article  PubMed  CAS  Google Scholar 

  101. Hwang SS, Scott CB, Chang VT, Cogswell J, Srinivas S, Kasimis B (2004) Prediction of survival for advanced cancer patients by recursive partitioning analysis: role of Karnofsky performance status, quality of life, and symptom distress. Cancer Invest 22:678–687

    Article  PubMed  Google Scholar 

  102. Herman MA, Tremont-Lukats I, Meyers CA, Trask DD, Froseth C, Renschler MF, Mehta MP (2003) Neurocognitive and functional assessment of patients with brain metastases. A pilot study. Am J Clin Oncol 26:273–279

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Virginia Health System, 800394, VA, 22908, Charlottesville, USA

    Lauren A. Chandler PsyD & Kathleen L. Fuchs Ph.D.

Authors
  1. Lauren A. Chandler PsyD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathleen L. Fuchs Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kathleen L. Fuchs Ph.D. .

Editor information

Editors and Affiliations

  1. , Laboratory of Molecular Pharmacology, National Cancer Institute, Convent Drive Building 3, Bethesda, 20892, Maryland, USA

    Diane Palmieri

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Chandler, L.A., Fuchs, K.L. (2012). Quality of Life with CNS Metastasis. In: Palmieri, D. (eds) Central Nervous System Metastasis, the Biological Basis and Clinical Considerations. Cancer Metastasis - Biology and Treatment, vol 18. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5291-7_11

Download citation

Publish with us

Policies and ethics

Search

Navigation